Skip to main content
Equibles

Assenagon Asset Management S.A.

Position in CRDF — Cardiff Oncology, Inc.

CIK 1546007 SENNINGERBERG, N4
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 21, 2026
Position Value
$87,400
-$21,514 QoQ
Shares Held
67,231
0.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 104 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,940,218,245 across 69 Biotechnology names. CRDF ranks #66 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 759,564 $377,298,225
2 ROIV
Roivant Sciences Ltd.
 8,362,952 $295,964,871
3 REGN
Regeneron Pharmaceuticals, Inc.
 244,927 $152,721,781
4 AXSM
Axsome Therapeutics, Inc.
 454,682 $111,292,513
5 BMRN
Biomarin Pharmaceutical Inc
 1,762,086 $100,826,560
6 HALO
Halozyme Therapeutics, Inc.
 997,643 $78,085,517
7 MDGL
Madrigal Pharmaceuticals, Inc.
 124,214 $66,696,707
8 TARS
Tarsus Pharmaceuticals, Inc.
 947,495 $59,635,335

All Filings in CRDF

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $87,400 67,231
2026-03-31 $108,914 67,231
2025-12-31 $188,919 67,231
2025-09-30 $138,495 67,231
2025-06-30 $211,777 67,231
2025-03-31 $211,105 67,231
2024-12-31 $291,782 67,231
2024-09-30 $722,296 270,523
2024-06-30 $2,699,346 1,215,922
2024-03-31 $1,350,923 252,982
2023-09-30 $117,138 84,272
2023-06-30 $209,369 142,428
2023-03-31 $651,740 394,994
2022-12-31 $251,360 179,543
2022-09-30 $256,462 166,534
2022-06-30 $341,418 155,190
2022-03-31 $804,660 324,460
2021-06-30 $174,010 26,167